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 50 
Abstract 51 
Introduction: Age-related changes in muscle mass and muscle tissue composition contribute to 52 
diminished strength in older adults. The objectives of this study are to examine if an assessment 53 
method using mobile diagnostic ultrasound augments well-known determinants of lean body mass 54 
(LBM) to aid sarcopenia staging, and if a sonographic measure of muscle quality is associated with 55 
muscle performance.   56 
Methods: Twenty community-dwelling female subjects participated in the study (age = 43.4 ±20.9 57 
years; BMI: 23.8, interquartile range: 8.5). Dual energy X-ray absorptiometry (DXA) and diagnostic 58 
ultrasound morphometry were used to estimate LBM. Muscle tissue quality was estimated via the 59 
echogenicity using grayscale histogram analysis.  Peak force was measured with grip dynamometry 60 
and scaled for body size. Bivariate and multiple regression analyses were used to determine the 61 
association of the predictor variables with appendicular lean mass (aLM/ht2), and examine the 62 
relationship between scaled peak force values and muscle echogenicity.  The sarcopenia LBM cut 63 
point value of 6.75 kg/m2 determined participant assignment into the Normal LBM and Low LBM 64 
subgroups. 65 
Results: The selected LBM predictor variables were body mass index (BMI), ultrasound 66 
morphometry, and age. Although BMI exhibited a significant positive relationship with aLM/ht2 (adj. 67 
R2 = .61, p < .001), the strength of association improved with the addition of ultrasound morphometry 68 
and age as predictor variables (adj. R2 = .85, p < .001). Scaled peak force was associated with age and 69 
echogenicity (adj. R2 = .53, p < .001), but not LBM. The Low LBM subgroup of women (n = 10) had 70 
higher scaled peak force, lower BMI, and lower echogenicity values in comparison to the Normal 71 
LBM subgroup (n = 10; p < .05). 72 
Conclusions: Diagnostic ultrasound morphometry values are associated with LBM, and improve the 73 
BMI predictive model for aLM/ht2 in women. In addition, ultrasound proxy measures of muscle 74 
quality are more strongly associated with strength than muscle mass within the study sample. 75 
  76 
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Introduction 77 
 78 
Age-related declines in strength typically begin during the 4th decade of life, and range from .6% to 79 
1.3% per year in people over 65 years of age (1–3). Sarcopenia, an age-related loss of muscle mass 80 
that contributes to diminished muscle power and independent mobility, has been noted as a 81 
significant cause of morbidity in older adults (4,5). The pathogenesis of sarcopenia is multifactorial 82 
and likely involves inflammatory, endocrine, neurological, and behavioral contributors. Importantly, 83 
the strength changes in older adults are often accompanied by myosteatosis, an increase in 84 
intramuscular adipose and connective tissue, along with the concomitant decrease in skeletal muscle 85 
cross-sectional area (1,6). These changes in muscle quality (e.g., muscle tissue composition, 86 
metabolic efficiency, or altered mechanics) may negatively impact functional performance in both 87 
women and men. Moreover, increased myosteatosis has been shown to be associated with decreased 88 
bone mineral density and lean body mass (LBM) in older women (7).   89 
 90 
Diminished LBM, muscle tissue composition, and muscle performance, are significant contributors 91 
to geriatric syndromes such as sarcopenia and frailty, and merit focused attention regarding 92 
standardized assessment and rehabilitation intervention strategies. Despite the substantial clinical and 93 
financial burden attributed to sarcopenia, it remains an under-diagnosed condition that is rarely 94 
subject to a systematic screening process for older adults (8). The most commonly used LBM 95 
criterion for sarcopenia staging is appendicular lean mass (aLM, also expressed as aLM/ht2), as 96 
measured by dual energy X-ray absorptiometry (DXA) (9,10). However, due to space requirements 97 
for DXA, initial equipment costs, body size constraints, and general barriers related to specialized 98 
LBM assessment software and examiner training, DXA assessment of aLM is not an ideal measure 99 
for large scale sarcopenia clinical trials, bedside assessment, or community health screening efforts. 100 
Individual attributes such as age and sex are meaningful determinants of LBM, and alternative 101 
anthropometric methods have been used to estimate LBM (11). In addition, BMI has been shown to 102 
explain a significant proportion of the variance in LBM values (12). However, these alternative 103 
estimates of LBM have limited utility as proxy measures, and the standard DXA examination does 104 
not provide information concerning muscle quality.   105 
 106 
The use of diagnostic ultrasound for body composition assessment has been explored in concurrent 107 
validity studies involving DXA, hydrostatic weighing, and computed tomography (CT) imaging 108 
(13,14). Also, sonographic characteristics of skeletal muscle have been associated with density values 109 
from magnetic resonance imaging (MRI) (15) and hydrodensitometry (16) in Japanese adults.  Unlike 110 
DXA, but similar to magnetic resonance and CT imaging, diagnostic ultrasound may be used to 111 
assess muscle quality via tissue characteristics. Muscle quality may be assessed via diagnostic 112 
ultrasound due to the hyperechoic nature of the non-contractile tissue associated with myosteatosis 113 
(17). The use of diagnostic ultrasound for muscle tissue characterization has also been successful in 114 
the detection of various disorders such as Duchenne muscular dystrophy (18–21). Moreover, the 115 
analysis of muscle tissue acquired via biopsy suggests that echogenicity is more strongly associated 116 
with intramuscular adipose tissue rather than fibrosis (22). Consequently, diagnostic ultrasound may 117 
be a practical alternative approach to the assessment of both muscle mass and muscle quality.  While 118 
there is some evidence to support the use of diagnostic ultrasound to estimate LBM (13,14,16), this 119 
method of body composition analysis is not widely used for sarcopenia screening and staging.  120 
Currently, diagnostic ultrasound is not identified as an accepted method to determine LBM by the 121 
major international sarcopenia consensus groups (23–25). Therefore, the objectives of this pilot study 122 
are to examine if a rapid assessment method via mobile diagnostic ultrasound augments well-known 123 
determinants of LBM to aid sarcopenia staging, and if a sonographic measure of muscle quality is 124 
associated with muscle performance.  125 
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 126 
 127 
 128 
Materials and Methods 129 
Participants. 130 
Twenty community-dwelling women were enrolled for participation in the study at the George 131 
Washington University (GW) Exercise Physiology Lab in Washington, DC.  The study was approved 132 
by the GW Office of Human Research Institutional Review Board, and registered with 133 
Clinicaltrials.gov (NCT00303446).  Signed informed consent was obtained from all study 134 
participants prior to data collection.  Inclusion criteria for study enrolment included being an 135 
ambulatory female adult between the ages of 18 and 75 years of age.  This sample of convenience 136 
was stratified to include an equal number of people above and below the age of 55. Federal agencies 137 
have identified the age range of 55 to 65 as a benchmark period to observe the emergence of age-138 
related health problems within U.S. populations (26). Absolute contraindications included pregnancy, 139 
medical conditions that result in edema, and musculoskeletal or neurological disorders that are 140 
associated with muscle atrophy.  Relative contraindications were body size dimensions that would 141 
preclude appropriate use of the DXA scanner.  Participant demographics are summarized in Table 1. 142 
 143 
 144 
Procedures. 145 
 146 
The primary estimate of LBM was obtained via whole body DXA imaging using a GE Lunar iDXA 147 
machine (GE Medical Systems Ultrasound & Primary Care Diagnostics, LLC, Madison, WI, USA).  148 
A single trained DXA technician administered all DXA examinations using the GE Encore v15 SP2 149 
software package for the LBM data acquisition and analysis.  The body composition data collected 150 
during the DXA examinations included estimates of absolute and percentage of total LBM, aLM/ht2, 151 
and body fat percentage (BF%).  The aLM values were calculated as the sum of LBM in the arms and 152 
legs and scaled to height (aLM/ht2).  Participant preparation and positioning for DXA was according 153 
to the GE DXA machine manufacturer’s manual and the GW Exercise Science Laboratory testing 154 
procedures.  DXA scans were obtained on the same day as the diagnostic ultrasound examination. 155 
Similar DXA imaging equipment and examination procedures (27) have yielded reliable 156 
measurement results  (ICC = 0.97, p < .0001; CV = 5.5% for LBM) (28). 157 
 158 
Sonographic estimates of LBM (aggregate muscle thickness, cm) and myosteatosis (echogenicity 159 
levels expressed as grayscale values, 0-255) were obtained by a single trained and certified 160 
sonographer.  Image capture was completed using a portable, diagnostic ultrasound device (SonoSite 161 
M-Turbo 1.1.2; SonoSite, Inc., Bothell, WA, USA) with a 13.6 MHz linear array transducer and B-162 
mode scanning. Ample amounts of water-soluble transmission gel was applied to the transducer in 163 
order to maintain adequate acoustic contact with the skin surface.  Minimal examiner pressure was 164 
exerted during the scanning to attain sufficient image resolution while incurring nominal tissue 165 
deformation. The unilateral (15) axial and appendicular sites included the midpoint of the upper 166 
trapezius, upper pectoralis major, lateral deltoid, proximal forearm (mobile wad compartment), and 167 
rectus femoris (dominant side only) as identified via palpation of surface anatomy and confirmed via 168 
real-time sonography. Imaging was completed while the participants were seated with their feet on 169 
the floor and upper arms relaxed and aligned with the trunk. Their elbows, hips, and knees were 170 
positioned with approximately 90º of flexion. These anterior locations were determined by 171 
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considering accessibility during their future use with non-ambulatory patients, the targeted region of 172 
interest (ROI) relative to the ultrasound imaging window and depth, previous use in other 173 
investigations, or clear anatomical landmarks that aid the imaging process (29,30).  All longitudinal 174 
view images were obtained and measured 3 times using digital calipers within the fascial boarders of 175 
the muscle at the time of image capture, and the values were averaged prior to analysis.  Acceptable 176 
intra-rater reliability (30,31) for diagnostic ultrasound assessment has been found for tests involving 177 
the thickness and cross-sectional area of the rectus femoris (ICC3,2 = 0.72-0.99, p < 0.05; CV = 3.5% 178 
to 6.7%) and similar morphology measures for the trapezius have also been reported as reliable 179 
(ICC3,3 = 0.88-0.96, p < 0.05). Also, the investigators involved in this study demonstrated a CV of 180 
1.6% to 2.9% for material thickness measures across 6 raters using a calibration phantom (32) and 181 
high interrater reliability (ICC2, k = .992 - .996, p < .001) for the assessment of echogenicity at the 182 
rectus femoris via grayscale histogram analysis (33).   183 
 184 
Additional assessments included hand grip dynamometry (Jamar, Lafayette Instruments, Lafayette, 185 
IN) using the mean value of 3 trials under standardized conditions (34). Grip strength is a frequently 186 
used impairment measure in studies concerning general muscle function and older adults (35), and 187 
the reliability of the Jamar dynamometer is suitable for clinical research settings (ICCs = 0.97-0.98, p 188 
< 0.01). Basic anthropometric measures such as height (cm) with a stadiometer and body mass (kg) 189 
with a balance scale were completed prior to body composition testing, and participants provided 190 
general information concerning racial/ethnic group identify, limb dominance (based on the stated 191 
preference for handwriting and kicking a ball), past medical history, alcohol intake (The Alcohol Use 192 
Disorders Identification Test, AUDIT-C) (36), health-related quality of life (The Health Assessment 193 
Questionnaire, HAQ) (37), and smoking behavior.   194 
 195 
 196 
Data Analysis. 197 
 198 
Descriptive statistics are used to depict participant characteristics and the outcome measures, and 199 
data are expressed as means and standard deviations.  The major outcomes in this study have normal 200 
data and variance distributions based on the Shapiro-Wilk and Levene’s test, respectively, except for 201 
the ultrasound echogenicity grayscale values and BMI.  These data are shown as median values with 202 
the interquartile range (IQR) and further analyses are completed using non-parametric statistics or 203 
log10(x) data transformations (38).  Inferential statistics include an analysis of relationships among 204 
the measures of body composition and muscle performance. Pearson product-moment correlation 205 
coefficients (PMCC, r), partial correlations (rxy•z), and Spearman’s correlation coefficients 206 
(Spearman’s rho, ρ) are used to assess the association between variables, and the strength of the 207 
association among the variables is based on Munro’s criteria (39).  Independent t-tests and Mann 208 
Whitney U tests are used to determine the difference among the variables based on the categorization 209 
of participants in “Normal LBM” and “Low LBM” subgroups.  The LBM criterion is based on the 210 
Class I designation for sarcopenia in women (5.76-6.75 kg/m2) by Janssen and colleagues (5).     211 
 212 
Nested linear multiple regression with a priori variable selection is used to assess the presumed 213 
association of LBM with measures of body size, ultrasound morphometry measures of muscle 214 
thickness, and age.  Significant improvements in the regression models are based of the change in F 215 
values derived from an analysis of variance (ANOVA).   Stepwise multiple linear regression analysis 216 
is used to determine the association of muscle strength with LBM, echogenicity, body size, body fat 217 
(BF), and age.  Data residuals are assessed for homoscedasticity and Cook’s Distance scores are 218 
assessed to ensure that individual data are not disproportionately influencing the regression equation.  219 
Multicollinearity of the covariates is initially assessed through the review of a correlation matrix, and 220 
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then calculating the variance inflation factors (VIF), tolerance statistics (1/VIF), and the covariate 221 
dependency associated with each eigenvalue following the regression analysis (40).  VIF values > 10 222 
denote multicollinearity, and an average VIF > 1 or 1/VIF < .1 prompts the review of the variance 223 
proportions associated with the eigenvalue dimensions for the final regression model.  Covariate 224 
dependency observed within any eigenvalue dimension will also serve to confirm the presence of 225 
multicollinearity. 226 
 227 
The construct of “strength” is represented by the averaged peak grip force values scaled to body 228 
weight given the well-known influence of body size on the expression on unadjusted strength values  229 
(kg of peak force/kg of body weight) (41,42).  Echogenicity measures are expressed as median 230 
grayscale values (a unitless 0-255 scale, with higher values indicating more hyperechoic material) via 231 
image analysis using Adobe Photoshop® version 6 (Adobe Systems, Mountain View, CA, USA) 232 
(33).  Total sample data and/or subgroup data were subject to analysis based on the nature of a given 233 
research question associated with the study objectives. Statistical analyses were performed using 234 
SPSS statistical software version 10.0 for Windows (SPSS Inc., Chicago, IL, USA).  The α level was 235 
set at .05, and two-tailed p values < .05 were considered significant for all inferential statistics.   236 
 237 
 238 
Results 239 
 240 
Participant characteristics 241 
 242 
Our sample includes 20 female participants with a mean age of 43.4 ±20.9 years with a median BMI 243 
of 23.8 (IQR, 8.5) and a mean aLM/ht2 of 6.96 ±1.22. Ratings of health-related quality of life via the 244 
HAQ were similar to those reported in population-based studies, no excessive alcohol intake was 245 
detected using the Audit-C questionnaire, and no participant reported a history of smoking (36,37).  246 
The assignment of participants to Normal LBM and Low LBM subgroups reveals that the Normal 247 
LBM subgroup exhibit higher BMI values (p = .001) and echogenicity levels (p = .003), but lower 248 
scaled grip strength values (p = .017) in comparison to the Low LBM group. Ultrasound estimates of 249 
LBM via aggregate total muscle thickness values significantly discriminate between the Normal 250 
LBM and the Low LBM subgroups (p = .006). All participant characteristics and demographic 251 
information are provided in Table 1. 252 
 253 
 254 
Using ultrasound muscle characteristics to improve predictors of lean body mass 255 
 256 
While ultrasound morphometry measures are independently associated with LBM (.64, p = .002), a 257 
multiple regression model using the aggregate ultrasound muscle thickness measures with estimates 258 
of body size and participant age provides the strongest association with DXA LBM values.  The 259 
iterations of the linear regression model show that BMI alone is a predictor of aLM/ht2 (adjusted R2 260 
of .61, p < .001, using log10(x) values for BMI).  However, the model is significantly improved ( R2 261 
= .13, F (2, 17) = 32.5, p < .004) with the addition of aggregate ultrasound muscle thickness 262 
(adjusted R2 of .77, p < .001) and age ( R2 = .08, F (3, 16) = 35.4, p < .007) as predictor variables.  263 
The a priori regression model of BMI, ultrasound muscle thickness, and age yields an adjusted R2 of 264 
.85 (p < .001; Table 2).  The partial correlations within this model show the strength of association 265 
between BMI and aLM/ht2 (rxy•z = .88).  Contributing predictor variables, ultrasound muscle thickness 266 
and age, exhibit a similar magnitude of association with aLM/ht2 (rxy•z =.58 and -.61, respectively).   267 
In examining the potential presence of multicollinearity within the regression model, the 1/VIF was 268 
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.66-.76 and the VIF was 1.3-1.5. The variance proportions associated with the eigenvalue dimensions 269 
do not reveal covariate dependency. The highest regression coefficient variances observed across all 270 
eigenvalue dimensions are for BMI (.97) and age (.16) within eigenvalue dimension 4 of the final 271 
regression model. 272 
 273 
 274 
 275 
 276 
Muscle quality estimates, body composition estimates, and peak force generation 277 
 278 
Estimates of muscle quality, proportion of total body fat, and age, but not LBM, are significantly 279 
associated with scaled peak force production.  Peak force generation was represented by dominant 280 
limb grip dynamometry scaled to body weight in our sample (differences between dominant and non-281 
dominant strength values were not significant; data not shown). Participant age and ultrasound 282 
echogenicity measured at the dominant limb rectus femoris are moderately associated with strength (r 283 
= -.69, p = .001, and ρ = -.67, p = .001, respectively). Considering the body composition measures 284 
obtained using DXA, percentage body fat (BF%) is  moderately associated with scaled peak force (r 285 
= -.63, p = .003), but LBM as estimated with aLM/ht2 is not (r = -.34, p = .14).   286 
 287 
The bivariate linear regression model with age as a predictor of scaled peak force yields an adjusted 288 
R2 of .39, p = .002.  The addition of ultrasound echogenicity, as quantified with grayscale histogram 289 
analysis (using log10(x) grayscale values), significantly improves the model ( R2 = .16, F (2, 18) = 290 
11.8, p = .017).  The multiple regression model with age and echogenicity as predictor variables 291 
accounts for approximately 53% of the variance in the scaled peak force values (p = .001; Table 3). 292 
The partial correlations within this model suggest that echogenicity may have a greater magnitude of 293 
association with scaled peak force (rxy•z = -.52) in comparison with participant age (rxy•z = -.38).  The 294 
addition of other predictor variables associated with body size and body composition, such as BMI 295 
and BF%, only serve to diminish the integrity of regression model (F value decreases from 13.3 to < 296 
7.9 without a resultant increase in the adjusted R2 value).  Regression model diagnostics are negative 297 
for multicollinearity based on a 1/VIF of .62, a VIF of 1.6, and an absence of covariate dependency 298 
within the eigenvalue dimensions.  Figure 1 depicts the scatterplot for scaled peak force and 299 
echogenicity expressed as grayscale values (log10(x)). 300 
 301 
 302 
Discussion 303 
 304 
Age-related muscle dysfunction may be marked by both a loss of LBM and diminished muscle tissue 305 
composition.  While the assessment of muscle quality is not yet included in the staging algorithm for 306 
sarcopenia (24), intrinsic muscle characteristics beyond size are known to affect strength and 307 
contribute to mobility limitations (43,44). Mobile, diagnostic ultrasound has been proposed as a 308 
method to obtain estimates of muscle mass and muscle quality, while circumventing the constraints 309 
of traditional imaging modalities related to access, cost, and radiation exposure (45,46).  The primary 310 
objectives of this study are to examine if diagnostic ultrasound muscle characteristics help to improve 311 
well-known determinants of LBM, and if the measurement of muscle quality via ultrasound 312 
echogenicity is associated with muscle performance. 313 
 314 
 315 
Diagnostic ultrasound and LBM estimates: improving on available clinical information  316 
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Standard clinical information such as age and BMI are significantly associated with LBM, but fall 317 
short of full consideration as proxy measures.  Our data is consistent with the findings of a larger 318 
study conducted by Iannuzzi-Sucich and colleagues (12) who determined that BMI independently 319 
accounts for approximately 50% of the variance in aLM/ht2. Also, Goodman and associates (47) have 320 
used logistic regression models with factors for BMI and age to identify older men and women with 321 
low aLM/ht2 based on data culled from the National Health and Nutrition Examination Surveys 322 
database (1999 to 2004) and comparisons with a young cohort reference group.  In this study, we 323 
have used a conceptual aLM/ht2 prediction model based on BMI, age, and a direct measure of muscle 324 
morphometry via diagnostic ultrasound.  The general use of BMI remains problematic (11,48) 325 
concerning the misclassification of very fit individuals as “overweight”, its potential overestimate of 326 
obesity rates in African Americans, and the wide range of BF% levels attributed to people with a 327 
BMI range between 20 and 30.  However, the value of retaining BMI within the proposed aLM/ht2 328 
prediction model is its significant association with LBM in many patient populations, and its 329 
representation of body size which serves to provide a scaling factor for the aggregate muscle 330 
thickness values obtained via sonography.  An additional potential benefit of using diagnostic 331 
ultrasound data for an aLM/ht2 prediction model, and during the general sarcopenia assessment 332 
process, is the viable opportunity to integrate estimates muscle quality into the sarcopenia staging 333 
algorithm.  The development of valid predictive models of LBM still remains an important goal 334 
concerning the staging of sarcopenia and the monitoring of other chronic conditions. Indeed, low 335 
LBM and muscle performance constitute health concerns that may act as independent mortality risk 336 
factors (49).  Nevertheless, muscle quality may surpass muscle mass as a contributor to age-related 337 
decreases in muscle strength and power, and negatively impact functional independence (50–52).  338 
Additional investigation will be needed to refine the operational definitions of muscle quality and to 339 
understand how to best incorporate this muscle characteristic into the sarcopenia syndrome 340 
framework.  341 
 342 
 343 
Muscle quality should not be ignored as a component of the sarcopenia syndrome  344 
 345 
Older adults categorized as mildly overweight based on their BMI are less likely to develop 346 
sarcopenia using LBM as the criterion (53). Individuals that are mildly overweight may exhibit a 347 
protective effect against muscle loss and maintain functional independence as they age despite a 348 
concomitant increased risk for cardiovascular disease and other systemic disorders (54).  Indeed, 349 
BMI significantly (p = .001) discriminates between participants in this study assigned to the Normal 350 
LBM subgroup (> 6.75 kg/m2) and Low LBM subgroup (5.76-6.75 kg/m2). The Normal LBM 351 
subgroup has a mean LBM value of 7.92 ±.88 kg/m2 and a BMI of 28.8 (IQR, 9.4), whereas the Low 352 
LBM subgroup has a mean LBM value of 6.00 ±.55 kg/m2 and a BMI of 21.5 (IQR, 3.1).  Therefore, 353 
the Normal LBM subgroup appears to reflect previously published findings concerning the LBM 354 
sparing effect of higher relative body weight levels.  Nevertheless, the Normal LBM subgroup also 355 
exhibits lower scaled peak force values and higher echogenicity values in comparison to the Low 356 
LBM subgroup (Figure 2).  The women assigned to the Low LBM subgroup are classified as having 357 
“healthy body weight” per the BMI designation, and they also have a lower proportion of total body 358 
fat, higher relative strength levels based on grip dynamometry, and better estimates of muscle quality 359 
(i.e., 35% lower echogenicity levels in comparison to the Normal LBM subgroup; Table 1). 360 
 361 
While forms of muscle quality are not part of the current sarcopenia staging algorithm, the concept 362 
remains useful for examining contributing factors to muscle performance. Muscle quality in 363 
sarcopenia studies is sometimes expressed as peak force generated from a single testing maneuver 364 
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scaled to regional DXA estimates of muscle mass (55,56).  Scaling net muscle force production 365 
relative to muscle mass or body mass allows one to compare strength within a heterogeneous sample 366 
regarding body stature, and account for the effect of body size on strength-function relationships 367 
(41).  Recently, the investigators involved in the Foundation for the National Institutes of Health 368 
(FNIH) Sarcopenia Project examined grip strength cut points related to mobility limitations. 369 
Although they opted to affirm the use of absolute strength values in a manner similar to other 370 
international sarcopenia consensus groups (24), they did note the modest improvements in the model 371 
equations for women within their pooled cross-sectional sample when using grip strength scaled to 372 
BMI (57).  While, the aforementioned scaling approach has been termed “specific force” in previous 373 
studies (55,56), there may be important distinctions between scaling factors and specific force that 374 
merit consideration.  Specific force has traditionally been determined by calculating muscle strength 375 
relative to whole muscle cross-sectional area (CSA), and is usually depicted as a simple linear 376 
relationship that may have some validity in unipennate muscles with fairly uniform architecture.  377 
However, the assumptions of specific force derived from CSA estimates do not apply to the vast 378 
majority of muscle groups.  Consequently, specific force is often formally expressed as the quotient 379 
of muscle force and physiologic cross-sectional area (PCSA), which incorporates aspects of muscle 380 
architecture such as muscle fiber length and pennation angle (58–60). Additional intrinsic factors 381 
such as moment arm length, muscle fiber type, muscle action mode, bioenergetics, excitation-382 
contraction coupling, and muscle tissue composition act to influence specific force.  Furthermore, 383 
factors extrinsic to the muscle – but inextricably linked with net force production – include sufficient 384 
cortical excitability, the integrity of pyramidal neurons, the synchrony and rate coding of alpha motor 385 
neurons, and the impact of age-related motor neuron loss (61,62).  Given the varied physiological 386 
factors that govern muscle performance, these insights imply that the use of specific force to 387 
represent muscle quality has important constraints. Rather, the calculation of specific force could be 388 
considered as one of many impairment-level outcomes that are responsive to changes in muscle 389 
quality and other facets of the neuromuscular milieu.  390 
 391 
In this report, muscle quality is operationally defined as muscle tissue echogenicity which serves as a 392 
proxy measure for tissue composition (17,22).  The rationale for considering diminished tissue 393 
composition as a major indicator of age-related muscle changes is partially validated through the 394 
significant inverse relationship between scaled peak force and echogenicity observed in our data 395 
(Figure 1). Given that LBM did not have a meaningful association with scaled peak force, and that 396 
age and echogenicity accounted for approximately 50% of the variance in strength levels, our pilot 397 
data allows for the consideration of additional intrinsic and extrinsic muscle factors contributing to 398 
the observed strength levels within the sample.   399 
 400 
 401 
Study implications and limitations  402 
 403 
The findings from this study suggest that diagnostic ultrasound may be used in combination with 404 
readily available clinical information to estimate LBM.  Although the models derived from the data 405 
must be considered exploratory given the limited sample size, the a priori explanatory variables lend 406 
strength to our general approach (40).  While the coefficients used in the regression equations may 407 
change substantially during validation with a larger sample and with the inclusion of male subjects, 408 
we hypothesize that the explanatory variables of BMI, ultrasound muscle thickness, and age will 409 
retain their value within the model.  Use of the Class I designation for sarcopenia in women (i.e., 410 
5.76-6.75 kg/m2) is appropriate for our participants given their relatively high level of physical 411 
functioning, and serves as an approach to discriminate meaningful body composition differences 412 
within the sample (5).  More stringent LBM criterion values, such as those ascribed to the Class II 413 
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sarcopenia designation or the FNIH sarcopenia staging algorithm, yield lower prevalence values (63) 414 
and may be more suitable for population-based studies with a sufficient representation of participants 415 
with a high degree of physical impairment. 416 
 417 
Muscle echogenicity was significantly associated with peak muscle force in our sample.  It is 418 
important to note that the sonographic morphology measures used for the proxy muscle tissue 419 
composition estimates were obtained at the rectus femoris.  The selection of the rectus femoris for 420 
echogenicity assessment is influenced by its favorable architecture and uniform geometry in the 421 
longitudinal orientation during scanning.  Previous observations confirm that echogenicity of skeletal 422 
muscles vary with their location within the body, with muscle groups within the lower compartment 423 
of the leg having higher echogenicity in comparison to selected upper body muscle groups (45,64).  424 
We hypothesized that while skeletal muscles have differing levels of echogenicity based on their 425 
location and metabolic profile, age-related changes in muscle tissue composition would be systemic 426 
and result in a broad increase in echogenicity across muscle groups. This proposed phenomenon is 427 
partially supported by our findings in this study concerning the observed significant relationship 428 
between echogenicity at the rectus femoris with peak grip force. Just as grip strength has been used 429 
as a global measure that may be significantly associated with knee extension strength and general 430 
physical performance in older adults (65,66), echogenicity at the knee extensors may be a general 431 
indicator of muscle quality that is inversely related with grip strength and general measures of muscle 432 
performance. For example, our preliminary data (67) involving a group of older men suggest that 433 
echogenicity levels at the rectus femoris are significantly related to scaled peak grip strength, walking 434 
speed, and the timed sit-to-stand test (r = -.30 to -.71, p < .05). Further study will be needed to better 435 
understand the effect of sexual dimorphism on the age-related changes in muscle tissue composition 436 
as assessed with sonographic proxy measures.  Also, larger follow up studies will be needed to 437 
explore the risk of incident mobility limitations and physical disability based on muscle quality 438 
estimates as described in this work. 439 
 440 
Investigators have also reported findings that suggest that changes in muscle tissue composition may 441 
differentially affect people of African descent (7,68,69).  Both advancing age and BF% may be 442 
associated with adverse changes in muscle tissue composition. However, high levels of intramuscular 443 
adipose tissue in African Americans may be observed in those classified as having “healthy body 444 
weight” based on their BMI, and be independent of central adiposity (69).  Individuals with this type 445 
of muscle tissue composition profile may have associated health problems that include metabolic 446 
dysfunction or diminished muscle performance, and yet not meet the staging criteria for sarcopenia.  447 
Indeed, there is some evidence to suggest that African Americans may have a lower prevalence of 448 
sarcopenia in comparison to non-Hispanic Whites (70).  We do not have a sufficient sample size to 449 
subject our racial/ethnic group data to inferential analysis.  However, we observed that none of our 450 
African American or Hispanic participants are in the Low LBM subgroup (Table 1).  These 6 451 
participants are in the Normal LBM subgroup which is characterized by higher mean BMI and 452 
median echogenicity values in comparison to the Low LBM subgroup. Other limitations in this work 453 
related to the modest sample size include the departures from normality related to the distribution of 454 
the BMI and grayscale values which was addressed via data transformation. Also, the constraints of 455 
standard diagnostic ultrasound imaging did not allow for us to obtain the additional measures of CSA 456 
or PSCA at the mid-thigh.  While grip dynamometry is the recommended means of strength testing 457 
according to the leading sarcopenia consensus organizations (10,23,25), the study findings may have 458 
been enhanced by obtaining estimates of lower extremity muscle performance. 459 
 460 
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It remains to be seen if screening for age-related changes in muscle quality may be effectively used to 461 
modify the risk of developing chronic disease and disabling conditions related to musculoskeletal 462 
health.  In addition, the benefits of diagnostic ultrasound to characterize skeletal muscle have to be 463 
considered with the shortcomings of the imaging modality related to equipment access, examiner 464 
training, limited normative datasets, and the inter-machine equivalence of echogenicity values (46). 465 
 466 
 467 
Conclusions 468 
 469 
Diagnostic ultrasound may provide a clinically viable means to assess both muscle mass and muscle 470 
quality.  Our study findings indicate that a conceptual aLM/ht2 prediction model based on BMI, age, 471 
and a direct measure of muscle morphometry via diagnostic ultrasound, accounts for 85% of the 472 
variance in DXA LBM values for our sample.  Moreover, our data suggest that age and muscle 473 
echogenicity, are significantly associated with scaled peak force production in the women that 474 
participated in our study.  In contrast, DXA LBM is not significantly associated with scaled peak 475 
force generation in our participants.  The higher total BF% of the Normal LBM subgroup may have 476 
conferred a protective effect against low muscle mass, but not myosteatosis.  The women in the 477 
Normal LBM subgroup exhibit higher BMI values and echogenicity levels, but lower scaled peak 478 
force values in comparison to the Low LBM group.  Follow up studies should include validation of 479 
the aLM/ht2 prediction model, and the integration of ultrasound estimates of muscle quality into the 480 
sarcopenia staging algorithm. 481 
 482 
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Tables 701 
 702 
Table 1. Participant characteristics. 703 
 704 
 705 
Subject Characteristics 
All  
subjects 
(N = 20) 
Normal  
LBM 
(N = 10) 
Low  
LBM 
(N = 10) 
Sig. 
Age (yrs) 43.4 ±20.9 47.9 ±21.3 39.0 ±20.4 .351 
BMI† 23.8 (8.5) 28.8 (9.4) 21.5 (3.1) .001 
aLM/ht2 (kg/m2 ) 6.96 ±1.22 7.92 ±.88 6.00 ±.55 <.001 
Grip strength (kgF/kgBW) .392 ±.089 .345 ±.095 .438 ±.054 .017 
Muscle thickness (cm)     
Trapezius 1.20 ±.19 1.27 ±.20 1.12 ±.15 .076 
Brachioradialis 1.95 ±.35 2.06 ±.40 1.84 ±.27 .170 
Deltoid 2.29 ±.53 2.54 ±.48 2.04 ±.45 .031 
Pectoralis major .78 ±.23 .85 ±.28 .70 ±.15 .163 
Rectus femoris 2.17 ±.54 2.34 ±.57 2.00 ±.48 .157 
Total muscle thickness (cm) 8.39 ±1.18 9.07 ±1.12 7.70 ±.81 .006 
Echogenicity†‡  47.50 (23.00) 58.50 (21.00) 38.00 (17.00) .003 
Racial/ethnic group     
Caucasian 9 (45.0%) 3 (30.0%) 6 (60.0%) - 
African American 4 (20.0%) 4 (40.0%) 0 (0.0%) - 
Hispanic 2 (10.0%) 2 (20.0%) 0 (0.0%) - 
Asian 5 (25.0%) 1 (10.0%) 4 (40.0%) - 
HAQ .45 ±1.10 .50 ±.97 .40 ±1.27 .605 
Audit-C† 2.0 (2.0) 2.0 (2.0) 2.0 (2.0) .586 
     
LBM, lean body mass; sig, significant; BMI, body mass index; aLM/ht2, appendicular lean mass scaled to 706 
height; F, force; BW, body weight; HAQ, The Health Assessment Questionnaire; Audit-C, The Alcohol Use 707 
Disorders Identification Test. 708 
 709 
Data expressed as means (± standard deviation); statistically significant differences between the Normal LBM 710 
subgroup and the Low LBM subgroup were determined using the independent t-test (p < .05). 711 
†Data expressed as medians (interquartile range); statistically significant differences between the Normal 712 
LBM subgroup and the Low LBM subgroup were determined using the Mann Whitney U test (p < .05).  713 
‡Echogenicity is expressed via grayscale values (0-255).  714 
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 715 
 716 
Table 2. Regression model for aLM/ht2. The linear regression model features lean body mass 717 
obtained from dual energy X-ray absorptiometry (DXA) as the dependent variable and the body mass 718 
index (BMI) with the aggregate muscle thickness value (US) and age as predictor variables.  719 
 720 
 721 
Model r R2  Adjusted R2 
Std. Error of the 
Estimate 
F Sig. 
1 .81 .66 .61 .731 35.1 <.001 
2 .89 .79 .77 .588 32.5 <.001 
3 .93 .87 .85 .482 35.4 <.001 
This a priori model utilized a nested linear, multiple regression model with forward entry – Predictors: 1) 722 
log10(BMI); 2) log10 (BMI) + aggregate muscle thickness (via ultrasound, cm); 3) log10 (BMI) + aggregate muscle 723 
thickness (via ultrasound, cm) + age (years).  Dependent Variable: DXA lean body mass (aLM/ht2). Model 3: Ŷ 724 
= -9.078 + 10.210(log10 (BMI)) + .302(US) + -.019(age). 725 
 726 
 727 
 728 
 729 
 730 
 731 
 732 
 733 
 734 
Table 3. Regression model for grip strength. The linear regression model features peak force 735 
obtained via grip dynamometry and scaled to body weight as the dependent variable and subject age 736 
and ultrasound echogenicity as estimated via grayscale analysis as the predictor variables.   737 
 738 
Model r R2  Adjusted R2 
Std. Error of the 
Estimate 
F Sig. 
1 .65 .42 .39 .068 13.26 .002 
2 .76 .58 .53 .059 11.75 .001 
This model utilized a nested linear multiple regression with forward variable entry – Predictors: 1) age; 2) age 739 
+ log10 (echogenicity via grayscale).  Dependent Variable: grip strength (scaled to body weight; dominant 740 
side).  Model 2: Ŷ = .969 - .306(log10 (echogenicity using grayscale values)) - .001(age). 741 
  742 
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 743 
Figure Legends 744 
Figure 1: Bivariate relationship between grip strength and muscle echogenicity. The scatterplot 745 
depicts the inverse relationship between grip strength (peak force scaled to body weight) and muscle 746 
quality as measured via grayscale histogram analysis of the rectus femoris echogenicity. 747 
 748 
 749 
  750 
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Figure 2: Diagnostic ultrasound image of the rectus femoris region of interest and the 751 
corresponding grayscale histogram analysis values. The exemplar images depict the diagnostic 752 
ultrasound transverse muscle images on the left and the grayscale histograms on the right. The 753 
bottom ultrasound image shows greater hyperechoic properties in comparison to the top image. The 754 
comparatively hyperechoic image characteristics of the bottom image correspond to grayscale 755 
histogram data with a wider distribution and a shift to the right which is associated with larger 756 
grayscale values.  The grayscale value of the bottom image is 66.9 and may indicate a greater 757 
proportion of intramuscular adipose tissue in comparison to the top image (grayscale value, 35.6).   758 
 759 
 760 
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